Cytek Biosciences Inc (CTKB) - Dodolan perusahaan

Cytek Biosciences, Inc. (CTKB) is implementing energy-efficient electronics and reducing reagent consumption in its analyzers. The company's sales timeline visualizes commercial rhythm, where 0.21 represents the current metric level. Strong spectrometer patents and strict FDA oversight create a defensive barrier, while the launch of automated cytometry software stimulates further business growth.

CTKB Cytek Biosciences Inc: Dodolan perusahaan ing interval 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Cytek Biosciences, Inc.

- nilai pasar lan prakiraan target analis:

Bagan bursa Cytek Corp|CTKB - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Biji pasar Cytek Biosciences, Inc.|CTKB - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data ekuitas miturut neraca:

Nilai Aset Bersih saben Saham Cytek Biosciences|CTKB - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku cytekbio.com|CTKB - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Utang marang Modal Cytek Biosciences, Inc.|CTKB - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Cytek Biosciences Inc|CTKB - Gunggung utang perusahaan|Rasio utang marang aset resik Cytek Biosciences, Inc.|CTKB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Cytek Biosciences|Koefisien jangkoan perantara cytekbio.com

- data bathi bisnis lan rasio investasi:

CTKB - Bathi resik perusahaan|Bathi resik sing dikarepake Cytek Biosciences, Inc.|CTKB - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi cytekbio.com|CTKB - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cytek Biosciences, Inc.|CTKB - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Cytek Biosciences|CTKB - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan cytekbio.com|CTKB - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Cytek Biosciences, Inc.

- rincian pendapatan lan dodolan emiten:

CTKB - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cytek Corp|CTKB - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cytek Biosciences, Inc.

Analisis umum perusahaan:Cytek Corp - CTKB

The growth of Cytek Biosciences, Inc. (CTKB) depends directly on the scaling of the Aurora ecosystem and the consumption of high-cost reagents. The company's current sales volume on the GURU.Markets platform illustrates the daily revenue dynamics from the sale of these products. This indicator assesses the resilience of cash flow to market volatility and technological pressure. Analysis of the curve allows for the identification of demand anomalies, signaling risks of the asset being overbought. The stability of this metric confirms the fundamental value of the capital.

Pesaing wigati